Alteration of SMRT tumor suppressor function in transformed non-Hodgkin lymphomas

Lynda Song, Andrei Zlobin, Pushpankur Ghoshal, Qing Zhang, Christiane Houde, Sanne Weijzen, Qun Jiang, Elizabeth Nacheva, Danny Yagan, Eric Davis, Sylvie Galiegue-Zouitina, Daniel Catovsky, Thomas Grogan, Richard I. Fisher, Lucio Miele, Lionel J. Coignet

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Indolent non-Hodgkin lymphomas are characterized by a prolonged phase that is typically followed by a clinical progression associated with an accelerated clinical course and short survival time. Previous studies have not identified a consistent cytogenetic or molecular abnormality associated with transformation. The development of a transformed phenotype, evolving from the original low-grade component, most likely depends on multiple genetic events, including the activation of synergistic dominant oncogenes and a loss of tumor suppressor gene functions. Complex karyotypes and relatively bad chromosome morphology are typical of transformed non-Hodgkin lymphomas, rendering complete cytogenetic analysis difficult. Here, we report the use of transformed non-Hodgkin lymphoma cell lines and primary samples to identify the involvement of the silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) gene that maps at chromosome 12q24 in transformed non-Hodgkin lymphomas. We also show that down-regulation of SMRT in the immortalized "Weinberg's model" cell lines induces transformation of the cells. Assessment of cDNA array profiles should further help us to design a working model for SMRT involvement in non-Hodgkin lymphoma transformation as a novel, nonclassical tumor suppressor.

Original languageEnglish (US)
Pages (from-to)4554-4561
Number of pages8
JournalCancer Research
Volume65
Issue number11
DOIs
StatePublished - Jun 1 2005
Externally publishedYes

Fingerprint

Non-Hodgkin's Lymphoma
Neoplasms
Nuclear Receptor Co-Repressor 2
Chromosomes
Cell Line
Cytogenetic Analysis
Oligonucleotide Array Sequence Analysis
Tumor Suppressor Genes
Karyotype
Oncogenes
Cytogenetics
Down-Regulation
Phenotype
Genes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Song, L., Zlobin, A., Ghoshal, P., Zhang, Q., Houde, C., Weijzen, S., ... Coignet, L. J. (2005). Alteration of SMRT tumor suppressor function in transformed non-Hodgkin lymphomas. Cancer Research, 65(11), 4554-4561. https://doi.org/10.1158/0008-5472.CAN-04-4108

Alteration of SMRT tumor suppressor function in transformed non-Hodgkin lymphomas. / Song, Lynda; Zlobin, Andrei; Ghoshal, Pushpankur; Zhang, Qing; Houde, Christiane; Weijzen, Sanne; Jiang, Qun; Nacheva, Elizabeth; Yagan, Danny; Davis, Eric; Galiegue-Zouitina, Sylvie; Catovsky, Daniel; Grogan, Thomas; Fisher, Richard I.; Miele, Lucio; Coignet, Lionel J.

In: Cancer Research, Vol. 65, No. 11, 01.06.2005, p. 4554-4561.

Research output: Contribution to journalArticle

Song, L, Zlobin, A, Ghoshal, P, Zhang, Q, Houde, C, Weijzen, S, Jiang, Q, Nacheva, E, Yagan, D, Davis, E, Galiegue-Zouitina, S, Catovsky, D, Grogan, T, Fisher, RI, Miele, L & Coignet, LJ 2005, 'Alteration of SMRT tumor suppressor function in transformed non-Hodgkin lymphomas', Cancer Research, vol. 65, no. 11, pp. 4554-4561. https://doi.org/10.1158/0008-5472.CAN-04-4108
Song, Lynda ; Zlobin, Andrei ; Ghoshal, Pushpankur ; Zhang, Qing ; Houde, Christiane ; Weijzen, Sanne ; Jiang, Qun ; Nacheva, Elizabeth ; Yagan, Danny ; Davis, Eric ; Galiegue-Zouitina, Sylvie ; Catovsky, Daniel ; Grogan, Thomas ; Fisher, Richard I. ; Miele, Lucio ; Coignet, Lionel J. / Alteration of SMRT tumor suppressor function in transformed non-Hodgkin lymphomas. In: Cancer Research. 2005 ; Vol. 65, No. 11. pp. 4554-4561.
@article{a804764aafd64fab9eabdad497fb0626,
title = "Alteration of SMRT tumor suppressor function in transformed non-Hodgkin lymphomas",
abstract = "Indolent non-Hodgkin lymphomas are characterized by a prolonged phase that is typically followed by a clinical progression associated with an accelerated clinical course and short survival time. Previous studies have not identified a consistent cytogenetic or molecular abnormality associated with transformation. The development of a transformed phenotype, evolving from the original low-grade component, most likely depends on multiple genetic events, including the activation of synergistic dominant oncogenes and a loss of tumor suppressor gene functions. Complex karyotypes and relatively bad chromosome morphology are typical of transformed non-Hodgkin lymphomas, rendering complete cytogenetic analysis difficult. Here, we report the use of transformed non-Hodgkin lymphoma cell lines and primary samples to identify the involvement of the silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) gene that maps at chromosome 12q24 in transformed non-Hodgkin lymphomas. We also show that down-regulation of SMRT in the immortalized {"}Weinberg's model{"} cell lines induces transformation of the cells. Assessment of cDNA array profiles should further help us to design a working model for SMRT involvement in non-Hodgkin lymphoma transformation as a novel, nonclassical tumor suppressor.",
author = "Lynda Song and Andrei Zlobin and Pushpankur Ghoshal and Qing Zhang and Christiane Houde and Sanne Weijzen and Qun Jiang and Elizabeth Nacheva and Danny Yagan and Eric Davis and Sylvie Galiegue-Zouitina and Daniel Catovsky and Thomas Grogan and Fisher, {Richard I.} and Lucio Miele and Coignet, {Lionel J.}",
year = "2005",
month = "6",
day = "1",
doi = "10.1158/0008-5472.CAN-04-4108",
language = "English (US)",
volume = "65",
pages = "4554--4561",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "11",

}

TY - JOUR

T1 - Alteration of SMRT tumor suppressor function in transformed non-Hodgkin lymphomas

AU - Song, Lynda

AU - Zlobin, Andrei

AU - Ghoshal, Pushpankur

AU - Zhang, Qing

AU - Houde, Christiane

AU - Weijzen, Sanne

AU - Jiang, Qun

AU - Nacheva, Elizabeth

AU - Yagan, Danny

AU - Davis, Eric

AU - Galiegue-Zouitina, Sylvie

AU - Catovsky, Daniel

AU - Grogan, Thomas

AU - Fisher, Richard I.

AU - Miele, Lucio

AU - Coignet, Lionel J.

PY - 2005/6/1

Y1 - 2005/6/1

N2 - Indolent non-Hodgkin lymphomas are characterized by a prolonged phase that is typically followed by a clinical progression associated with an accelerated clinical course and short survival time. Previous studies have not identified a consistent cytogenetic or molecular abnormality associated with transformation. The development of a transformed phenotype, evolving from the original low-grade component, most likely depends on multiple genetic events, including the activation of synergistic dominant oncogenes and a loss of tumor suppressor gene functions. Complex karyotypes and relatively bad chromosome morphology are typical of transformed non-Hodgkin lymphomas, rendering complete cytogenetic analysis difficult. Here, we report the use of transformed non-Hodgkin lymphoma cell lines and primary samples to identify the involvement of the silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) gene that maps at chromosome 12q24 in transformed non-Hodgkin lymphomas. We also show that down-regulation of SMRT in the immortalized "Weinberg's model" cell lines induces transformation of the cells. Assessment of cDNA array profiles should further help us to design a working model for SMRT involvement in non-Hodgkin lymphoma transformation as a novel, nonclassical tumor suppressor.

AB - Indolent non-Hodgkin lymphomas are characterized by a prolonged phase that is typically followed by a clinical progression associated with an accelerated clinical course and short survival time. Previous studies have not identified a consistent cytogenetic or molecular abnormality associated with transformation. The development of a transformed phenotype, evolving from the original low-grade component, most likely depends on multiple genetic events, including the activation of synergistic dominant oncogenes and a loss of tumor suppressor gene functions. Complex karyotypes and relatively bad chromosome morphology are typical of transformed non-Hodgkin lymphomas, rendering complete cytogenetic analysis difficult. Here, we report the use of transformed non-Hodgkin lymphoma cell lines and primary samples to identify the involvement of the silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) gene that maps at chromosome 12q24 in transformed non-Hodgkin lymphomas. We also show that down-regulation of SMRT in the immortalized "Weinberg's model" cell lines induces transformation of the cells. Assessment of cDNA array profiles should further help us to design a working model for SMRT involvement in non-Hodgkin lymphoma transformation as a novel, nonclassical tumor suppressor.

UR - http://www.scopus.com/inward/record.url?scp=21144435931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21144435931&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-04-4108

DO - 10.1158/0008-5472.CAN-04-4108

M3 - Article

C2 - 15930272

AN - SCOPUS:21144435931

VL - 65

SP - 4554

EP - 4561

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 11

ER -